It’s possible that an off-label usage lawsuit led to more off-label usage NEW YORK (Reuters Health) - In 2004, Pfizer, the world's largest drug company, agreed to plead guilty and pay more than $430 million to settle charges it had illegally marketed the epilepsy drug Neurontin for unapproved uses. Now, a study in the Journ... [News Source]